Speed Medical results, Q1 2024
Net profit, assets, equity and cash flow for Q1 2024, against the same period a year earlier, from the published financial statements.
Net profit-25.45 millionEGP · −5.2% vs the same period a year earlier
Total assets547 millionEGP · −7.1% vs the same period a year earlier
Shareholders' equity281 millionEGP · +9.0% vs the same period a year earlier
Operating cash flow10.87 millionEGP · −38.7% vs the same period a year earlier
In short
- Speed Medical's net profit for Q1 2024 was about -25.45 million EGP, down −5.2% from -24.18 million EGP in Q1 2023.
- Total assets at the end of Q1 2024 were about 547 million EGP, and shareholders' equity about 281 million EGP.
- Operating cash flow for Q1 2024 was positive at 10.87 million EGP.
Key lines against the same period a year earlier
This periodQ1 2023Change
Net profit-25.45 million-24.18 million−5.2%
Gross profit-6.33 million-1.03 million−517.8%
Total assets547 million589 million−7.1%
Total liabilities266 million331 million−19.5%
Shareholders' equity281 million257 million+9.0%
Total liabilities and equity547 million589 million−7.1%
Operating cash flow10.87 million17.72 million−38.7%
Investing cash flow-136 thousand-3.82 million+96.4%
Financing cash flow-12.26 million-13.49 million+9.2%
Net change in cash-1.53 million410 thousand−472.6%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy